Amedisys Inc. Stock
Price
Target price
€83.50
€83.50
-0.600%
-0.5
-0.600%
€92.26
25.04.24 / Frankfurt
WKN: 915582 / Symbol: AMED / Name: Amedisys / Stock / Healthcare Providers & Services / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Amedisys Inc. Stock
Amedisys Inc. shows a slight decrease today, losing -€0.500 (-0.600%) compared to yesterday.
Amedisys Inc. is currently one of the favorites of our community with 13 Buy predictions and no Sell predictions.
As a result the target price of 92 € shows a slightly positive potential of 10.18% compared to the current price of 83.5 € for Amedisys Inc..
Pros and Cons of Amedisys Inc. in the next few years
Pros
?
B****
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
C******** o* t** e**********
?
M***** P*******
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Amedisys Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Amedisys Inc. | -0.600% | 0.599% | 0.599% | 19.149% | -0.592% | -64.103% | -23.147% |
| Amn Healthcare Svs | -0.950% | 0.962% | -7.895% | -33.544% | -21.642% | -17.969% | 18.644% |
| Ensign Group Inc. | -1.800% | 0.000% | -3.509% | - | 6.796% | - | - |
| Chemed Corp. | -0.880% | 1.786% | -3.390% | 12.871% | 9.615% | 47.668% | 94.373% |
Comments
Amedisys, Inc. (NASDAQ: AMED) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Show more
Ratings data for AMED provided by MarketBeat
Amedisys, Inc. (NASDAQ: AMED) had its price target raised by analysts at Royal Bank of Canada from $97.00 to $100.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for AMED provided by MarketBeat
Amedisys, Inc. (NASDAQ: AMED) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Show more
Ratings data for AMED provided by MarketBeat